TG Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

TG Therapeutics

04/11/2024 15:20

* TG Therapeutics Inc  TGTX.OQ  reported quarterly adjusted
earnings of 2 cents​​ per share for the quarter ended September
30, lower than the same quarter last year, when the company
reported EPS of 73 cents.  The mean expectation of
eight analysts for the quarter was for earnings of 3 cents per
share. Wall Street expected results to range from -5 cents to 8
cents per share.
    * Revenue fell 49.4% to $83.88 million from a year ago;
analysts
expected $81.71 million. 
    * TG Therapeutics Inc's reported EPS for the quarter was 2
cents​.
    * The company reported quarterly net income of $3.88
million.
    * TG Therapeutics Inc shares had risen by 15.0% this
quarter and
gained 57.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 616.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for TG Therapeutics
Inc is 41.50 
This summary was machine generated from LSEG data November 4 at
03:20 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.03           0.02           Missed
 Jun. 30 2024      -0.05          0.04           Beat
 Dec. 31 2023      -0.04          -0.07          Missed
 Dec. 31 2023      -0.10          -0.10          Met